X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


Latest Post

May 31, 2019

Stability Studies of Pharmaceutical Packaging Materials in China

The regulatory landscape in China continues to evolve and become more stringent. In December 2018, the Chinese Pharmacopoeia Commission (ChPC) published: Second Draft for Comments on Guideline for Stability Study of Plastic and Rubber Pharmaceutical Packaging Materials. This guideline comprises part of the results of a research project organized by ChPC in 2016 and is one of the actions taken by National Drug Administration of China (formerly the China Food and Drug Administration, CFDA) to support the previously announced Opinions on Reforming the Review and Approval System for Drugs and Medical Devices (No. 44).
Lynn Yao

Lynn Yao

Manager, Scientific Affairs, AP

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}